Concepedia

Tiffany Chang

TC

31

Publications

2.7K

Citations

23

H-Index

1982

Active since

Affiliations

Roche (Switzerland)(Current)

University of Southern California

Children's Hospital of Los Angeles

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Emory University

Tiffany Chang is an author at Roche (Switzerland) specializing in medicine, hematology, and immunology.

ORCID

Top concepts

Publications per year

1982–2023

31

Publications

31

A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors

Guy Young, Ri Liesner, Tiffany Chang et al. · Blood · 2019 · 361 citations · Full text

Platelet‐derived growth factor is a chemoattractant for vascular smooth muscle cells

Gary R. Grotendorst, Tiffany Chang, H. Seppä et al. · Journal of Cellular Physiology · 1982 · 336 citations

The genomic landscape of juvenile myelomonocytic leukemia

Elliot Stieglitz, Amaro Taylor‐Weiner, Tiffany Chang et al. · Nature Genetics · 2015 · 305 citations · Full text

, , +7

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies

Michael U. Callaghan, Claude Négrier, Ido Paz‐Priel et al. · Blood · 2020 · 270 citations · Full text

, , +15

Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

Lindsey A. George, Paul E. Monahan, M. Elaine Eyster et al. · New England Journal of Medicine · 2021 · 234 citations · Full text

Rows per page

1–5 of 31